T. Rowe Price Associates’s ATRenew RERE Stock Holding History

T. Rowe Price Associates’s Portfolio RERE Stock Details RERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.6M	Buy	4,183,954 +326,270	+8%	+$1.84M	﹤0.01%	1042
2025 Q4	$20.4M	Buy	3,857,684 +1,450,764	+60%	+$6.5M	﹤0.01%	1054
2025 Q3	$11.1M	Buy	2,406,920 +201,687	+9%	+$812K	﹤0.01%	1202
2025 Q2	$7.3M	Sell	2,205,233 -33,801	-2%	-$87.9K	﹤0.01%	1187
2025 Q1	$6.58M	Sell	2,239,034 -60,373	-3%	-$177K	﹤0.01%	1198
2024 Q4	$6.62M	Buy	+2,299,407	New	+$6.4M	﹤0.01%	1217

Other funds holding RERE

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TPC

Tiger Pacific Capital New York $410M AUM 0.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates's RERE Position: Q1 2026 in Review

T. Rowe Price Associates increased its ATRenew (RERE) stake by 8.5% in Q1 2026, buying an estimated $1.84M and bringing the position to 4,183,954 shares worth $19.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

T. Rowe Price Associates first reported a position in RERE in Q4 2024 and has held it in 6 quarters since. The position peaked at $20.4M in Q4 2025. 82 funds tracked by Wall St. Rank hold RERE as of Q1 2026.

T. Rowe Price Associates held 4,183,954 shares of ATRenew worth $19.6M as of Q1 2026.
T. Rowe Price Associates bought 326,270 ATRenew shares in Q1 2026, an estimated $1.84M.
ATRenew made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1042 holding.
T. Rowe Price Associates first reported a position in ATRenew in Q4 2024 and has held it in 6 quarters since.
T. Rowe Price Associates's ATRenew position peaked at $20.4M in Q4 2025.
82 funds tracked by Wall St. Rank held ATRenew as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.